Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix

Cancer Research

Volumn 58, Issue 3, 1998, Pages 426-431

  Bandiera, Antonella ^a   Bonifacio, Daniela ^a   Manfioletti, Guidalberto ^a   Mantovani, Fiamma ^a   Rustighi, Alessandra ^a   Zanconati, Fabrizio ^a   Fusco, Alfredo ^b   Di Bonito, Luigi ^a   Giancotti, Vincenzo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; MONOCLONAL ANTIBODY KI 67; POLYCLONAL ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE SECTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0032005220     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lund, T., Holtlund, J., Fredriksen, M., and Laland, S. G. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett., 152: 163-167, 1983.
2. Goodwin, G. H., Cockerill, P. N., Kellam, S., and Wright, C. A. Fractionation by high-performance liquid chromatography of the low-molecular-mass high-mobility group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus-transformed cells. Eur. J. Biochem., 149: 47-51, 1985.
3. Giancotti, V., Berlingieri, M. T., Di Fiore, P. P., Fusco, A., Vecchio, G., and Crane-Robinson, C. Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res., 45: 6051-6057, 1985.
4. Giancotti, V., Pani, B., D'Andrea, P., Berlingieri, M. T., Di Fiore, P. P., Fusco, A., Vecchio, G., Philp, R., Crane-Robinson, C., Nicolas, R. H., Wright, C. A., and Goodwin, G. H. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J., 6: 1981-1987, 1987.
5. Giancotti, V., Bandiera, A., Buratti, E., Fusco, A., Marzari, R., Coles, B., and Goodwin, G. H. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein. Eur. J. Biochem., 198: 211-216, 1991.
6. Strauss, F., and Varshavsky, A. A protein binds to a satellite DNA repeat at three sites that would be brought into mutual proximity by DNA folding in the nucleosome. Cell, 37: 889-901, 1984.
7. Solomon, M. J., Strauss, F., and Varshavsky, A. A mammalian high mobility group protein recognizes any stretch of six A·T base pairs in duplex DNA. Proc. Natl. Acad. Sci. USA. 83: 1276-1280, 1986.
8. Elton, T. S., Nissen, M. S., and Reeves, R. Specific A·T DNA sequence binding of RP-HPLC purified HMG-I. Biochem. Biophys. Res. Commun., 143: 260-265, 1987.
9. Reeves, R., Elton, T. S., Nissen, M. S., Lehn, D., and Johnson, K. R. Post-translational gene regulation and specific binding of the nonhistone protein HMG-I by 3′ untranslated region of bovine interleukin 2 cDNA. Proc. Natl. Acad. Sci. USA, 84: 6531-6535, 1987.
10. Disney, J., Johnson, K. R., Magnuson, N. S., Sylvester, S. R., and Reeves, R. High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J. Cell Biol., 109: 1975-1982, 1989.
11. Radic, M. Z., Saghbini, M., Elton, T. S., Reeves, R., and Hamkalo, B. Hoechst 33258, distamycin A, and high mobility group I (HMG-I) compete for the binding to mouse satellite DNA. Chromosoma (Berl.), 101: 602-608, 1992.
12. Johnson, K. R., Lehn, D. A., Elton, T. S., Barr, P. J., and Reeves, R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol. Chem., 263: 18338-18342, 1988.
13. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiére, P., Cary, P., Crane-Robinson, C., and Goodwin, G. H. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19: 6793-6797, 1991.
14. Patel, U. A., Bandiera, A., Manfioletti, G., Giancotti, V., Chau, K. Y., and Crane-Robinson, C. Expression and cDNA cloning of the human high-mobility-group protein HMGI-C. Biochem. Biophys. Res. Commun., 201: 63-70, 1994.
15. Thanos, D., and Maniatis, T. NF-κB: a lesson in family values. Cell, 80: 529-532, 1995.
16. Thanos, D., and Maniatis, T. The high mobility group protein HMGI(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell, 71: 777-789, 1992.
17. Du, W., Thanos, D., and Maniatis, T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell, 74: 887-898, 1993.
18. Fashena, S. J., Reeves, R., and Ruddle, N. H. A poly(dA-dT) upstream activating sequence binds high-mobility-group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation. Mol. Cell. Biol., 12: 894-903, 1992.
19. John, S., Reeves, R., Lin, J. X., Child, R., Leiden, J. N., Thompson, C. B., and Leonard, W. J. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol. Cell. Biol., 15: 1786-1796, 1995.
20. Schoenmakers, E. F. P. M., Wanshura, S., Mois, R., Bullerdiek, J., Van den Berghe, H., and Van de Ven, W. J. M. Recurrent rearrangements in the high mobility group gene, HMGI-C, in benign mesenchymal tumours. Nat. Genet., 10: 436-444, 1995.
21. Wanshura, S., Belge, G., Stenman, G., Kools, P., Dal Cin, P., Schoenmakers, E. F. P. M., Huysmans, C. Bartnitzke, S., Van de Ven, W. J. M., and Bullerdiek, J. Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosoma 12. Cancer Genet. Cytogenet., 86: 39-45, 1996.
22. Kazmierczak, B., Risgkeit, J., Wanshura, S., Meyer-Bolte, K., Van de Ven, W. J. M., Kayser, K., Krieghoff, B., Kastendiek, H., Bartnitzke, S., and Bullerdiek, J. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene, 12: 515-521, 1996.
23. Zhou, X., Benson, K. F., Ashar, H. R., and Chada, K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature (Lond.), 376: 771-774, 1995.
24. Hofstädter, F., Knüchel, R., and Rüschoff, J. Cell proliferation assessment in oncology. Virchows Arch., 427: 323-341, 1995.
25. Palmies, R. J., and Crawford, D. R. Tumor markers: an update. Med. Clin. North Am., 80: 185-199, 1996.
26. Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Balmain, A., Portella, G., Fusco, A., and Goodwin, G. H. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res., 184: 538-545, 1989.
27. Giancotti, V., Bandiera, A., Ciani, L., Santoro, D., Crane-Robinson, C., Goodwin, G. H., Boiocchi, M., Dolcetti, R., and Casetta, B. High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur. J. Biochem., 213: 825-832, 1993.
28. Bussemakers, M. J. G., Van de Ven, W. J. M., Debruyne, F. M. J., and Schalken, J. A. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
29. Tamimi, Y., Van der Poel, H. G., Karthaus, H. F. M., Debruyne, F. M. J., and Schalken, J. A. A retrospective study of high mobility group protein I(Y), a progression marker for prostate cancer determined by in situ hybridization. Br. J. Cancer, 74: 573-578, 1996.
30. Chiappetta, G., Bandiera, A., Berlingieri, M. T., Visconti, R., Manfioletti, G., Battista S., Martinez-Tello, F. J., Santoro, M., Giancotti, V., and Fusco, A. The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene, 10: 1307-1314, 1995.
31. Fedele, M., Bandiera, A., Chiappetta, G., Battista, S., Viglietto, G., Manfioletti, G., Casamassimi, A., Santoro, M., Giancotti, V., and Fusco, A. Human colorectal carcinomas expresses high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56: 1896-1901, 1996.
32. Manfioletti, G., Gattei, V., Buratti, E., Rustighi, A., De Iuliis, A., Aldinucci, D., Goodwin, G. H., and Pinto, A. Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood, 85: 1237-1245, 1995.
33. Schlüter, C., Duchrow, M., Wohlenberg, C., Becker, M. H. G., Key, G., Flad, H-D., and Gerdes, J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol., 123: 513-522, 1993.
34. Al-Saleh, W., Delvenne, P., Greimers, R., Fridman, V., Doyen, J., and Boniver, J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Am. J. Clin. Pathol., 104: 154-160, 1995.
35. Isacson, C., Kessis, T. D., Hedrick, L., and Cho, K. R. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res., 56: 669-674, 1996.
36. Kube, D., Janda, J., Johannsmeyer, K. D., and Bergamann, S. Characterization of human papillomavirus type 16 activity in separate biopsies from a carcinoma of the cervix uteri. Virchows Arch., 425: 473-480, 1994.
37. Gerdes, J., Li, L., Schlüter, C., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., and Flad, H. D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol., 138: 867-873, 1991.
38. Bustin, M., and Reeves, R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. In: W. E. Cohn and K. Moldave (eds.), Progress in Nucleic Acid Research and Molecular Biology, Vol. 54, pp. 35-100. San Diego, CA: Academic Press, 1996.
39. Ram, T. G., Reeves, R., and Hosick, H. L. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53: 2655-2660, 1993.
40. Tamimi, Y., Van der Poel, H. G., Denyn, M-M., Umbas, R., Karthaus, H. F. M., Debruyne, F. M. J., and Schalken, J. A. Increased expression of high mobility group protein I(Y) in high-grade prostatic cancer determined by in situ Hybridization. Cancer Res., 53: 5512-5516, 1993.
41. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15: 1545-1553, 1995.
42. Tallini, G., Dal Cin, P., Rhoden, K. L. Chiappetta, G., Manfioletti, G., Giancotti, V., Fusco, A., Van den Berghe, H., and Sciot, R. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am. J. Pathol., 151: 37-43, 1997.
43. Choong, P. F. M., Åkerman, M., Wilĺen, H., Anderson, C., Gustafson, P., Baldetorp, B., Fernö, M., Alvegård, T., and Rydholm, A. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation-a marker of metastasis? APMIS, 102: 915-924, 1994.
44. Takano, Y., Saegusa, M., Ikenaga, M., Mitomi, H., and Okayasu, I. Apoptosis of colon cancer: comparison with Ki-67 proliferative activity and expression of p53. J. Cancer Res. Clin. Oncol., 122: 166-170, 1996.
45. Okayasu, I., Saegusa, M., Fujiwara, M., Hara, Y., and Rose, N. R. Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. J. Cancer Res. Clin. Oncol., 121: 746-752, 1995.
46. Katoh, R., Bray, C. E., Suzuki, K., Komiyama, A., Hemmi, A., Kawaoi, A., Oyama, T., Sugai, T., and Sasou, S. Growth activiy in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum. Pathol., 26: 139-146, 1995.
47. Healy, E., Angus, B., Lawrence, C. M., and Rees, J. L. Prognostic value of Ki67 antigen expression in basal carcinomas. Br. J. Dermatol., 133: 737-741, 1995.
48. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, B., Trapasso, F., Merciai, B. M., Fidanza, V., Giancotti, V., Santoro, M., Simeone, A., and Fusco, A. High level expression of the HMGI(Y) gene during embryonic development. Oncogene, 13: 2439-2446, 1996.